“Right-to-Try” experimental drugs: an overview

The “Right-to-Try” experimental drugs act passed by Donald Trump in 2018 provides an opportunity of early access to experimental drugs for the treatment of life-threatening diseases and a potential boon to man...

Source: Journal of Translational Medicine - June 23, 2020 Category: Research Authors: Vijay Mahant Tags: Review Source Type: research